Clinical Trial Update: Omission of SLNB in CN0 Early Breast Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating the omission of sentinel lymph node biopsy in clinically node-negative early breast cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes | NA | Status: RECRUITING